Below are 9 news articles from the past week to help guide you in making your decision.

Article 1 of 9
Title: Canadian cannabis legalization linked to increased and decreased hospitalization, depending on the province
Publisher: Medical Xpress
Posted: 1 day ago
The article reports on cannabis-related hospitalization rates in Ontario and other provinces before and after legalization in Canada. Key findings include:
A sharp increase in cannabis-related hospitalizations in Ontario (20% increase) following widespread commercialization.
The COVID-19 pandemic's association with a rise in cannabis-related hospitalizations, particularly for cannabis-induced psychosis.
Different approaches to cannabis retail store access and product expansion across provinces, which may impact public health burden.
Values most important for forecasting COVID-19 hospitalizations in Ontario, Canada:
Cannabis-related hospitalization rates
Commercialization and product expansion timelines
COVID-19 pandemic's association with increased hospitalizations

Article 2 of 9
Title: COVID-19 trends high and stable in and around Ottawa
Publisher: CBC News
Posted: 2 days ago
Average number of Ottawa residents in local hospitals for COVID-19 is stable at 25 (moderate level).
Kingston area's health unit reports very high 15 active COVID-19 patients in its hospitals.
Renfrew County has a stable 3 hospitalizations and the Eastern Ontario Health Unit (EOHU) has a stable 15 hospitalizations.
Wastewater data shows rising coronavirus levels, considered very high by Ottawa Public Health.

Article 3 of 9
Title: Canadian data misused to make false claims about Covid-19 vaccines
Publisher: AFP Factcheck
Posted: 3 days ago
The efficacy of COVID-19 vaccines wanes over time.
A third dose improves protection against both infection and hospitalization due to the Omicron variant.
Booster doses provide additional protection, including against severe disease.
The duration of protection is currently unknown.

Article 4 of 9
Title: Inflammatory diseases don't boost clotting risks post-COVID, study reveals
Publisher: News-Medical.Net
Posted: 3 days ago
The study used population-based data from Ontario, Canada.
The data included health administration interactions, emergency department visits, hospitalizations, and physician billings.
The study found that individuals with immune-mediated inflammatory diseases (IMIDs) did not have a significantly higher risk of venous thromboembolisms after recovering from SARS-CoV-2 infections compared to those without IMIDs.
Comorbidities were found to confound the association between venous thromboembolism events and IMIDs following SARS-CoV-2 infections.

Article 5 of 9
Title: B.C. expands COVID-19 wastewater monitoring to Prince George
Publisher: CBC News
Posted: 3 days ago
Relevant.
Summary: The article discusses a COVID-19 wastewater monitoring program in British Columbia (B.C.), Canada. Key points include:
Wastewater samples are collected from sewage treatment plants and tested for viruses like COVID-19.
This method provides unbiased and consistent population-level data, which can inform public health responses.
Data shows increasing levels of COVID-19 in Prince George, but not significant levels of Influenza A or B.
Note: While the article is about a wastewater monitoring program in British Columbia, it highlights the potential for this type of surveillance to provide valuable information on population-level trends, which could be relevant for forecasting COVID-19 hospitalizations in Ontario, Canada.

Article 6 of 9
Title: Cannabis Commercialization Linked to More Hospitalizations
Publisher: Medscape
Posted: 4 days ago
The study period includes data from March 2020 to March 2021, which coincides with the COVID-19 pandemic.
During this period, there was an immediate increase of 0.83 hospitalizations due to cannabis per 100,000 individuals.
The article mentions that Ontario is one of the four most populous provinces in Canada where the study was conducted.
However, the article does not provide specific data on COVID-19 hospitalizations in Ontario.
Note: While the article provides some relevant information for forecasting COVID-19 hospitalizations in Ontario, Canada, it is primarily focused on the effects of cannabis commercialization on hospitalizations.

Article 7 of 9
Title: 5 years of legal cannabis: fewer charges, many hospitalizations and more than a few questions
Publisher: CBC News
Posted: 4 days ago
The study analyzed hospitalization data on nearly 7 million people aged 15 and up in Ontario from January 2015 to March 2021.
There were 105,000 hospitalizations for cannabis over the 7-year period, with one-third among people aged 15-24 and 66% among males.
The rate of hospitalizations didn't change during the early years of legalization but increased during the commercialization period (March 2020 to March 2021), particularly among people aged 25 and older.

Article 8 of 9
Title: Quebecers can now get a new COVID-19 shot. What you need to know about the virus and vaccines
Publisher: CBC News
Posted: 4 days ago
Hospitalizations are on the rise in Quebec due to circulating cases (1,493 people hospitalized with COVID-19 as of Oct. 3).
The province has seen an uptick in cases and hospitalizations since August.
Case numbers are severely underrepresented, with estimated daily new cases ranging from 20,000 to 30,000.
Hospitalization data is available for Quebec, which can be used for comparison or forecasting purposes.

Article 9 of 9
Title: How seniors can access 4 key vaccines this fall — for COVID, flu, pneumonia, and RSV
Publisher: CBC News
Posted: 7 days ago
Here's a brief summary highlighting values most important for forecasting COVID-19 hospitalizations in Ontario, Canada:
Updated COVID vaccines are being rolled out in the fall, which may impact hospitalization rates.
The new RSV vaccine is not expected to be co-administered with other shots, and its impact on hospitalization rates is unclear.
Hospitalization rates for COVID-19 have been higher among adults aged 65 and up, accounting for approximately 63% of all COVID-related hospitalizations in the US in 2023.
The case fatality rate of pneumococcal pneumonia is typically up to 7%, with even higher rates among the elderly.